Bill
Bill > HB1339
TX HB1339
TX HB1339Relating to designating certain substances as Schedule IV controlled substances under the Texas Controlled Substances Act.
summary
Introduced
11/14/2024
11/14/2024
In Committee
03/10/2025
03/10/2025
Crossed Over
Passed
Dead
06/02/2025
06/02/2025
Introduced Session
89th Legislature Regular Session
Bill Summary
AN ACT relating to designating certain substances as Schedule IV controlled substances under the Texas Controlled Substances Act.
AI Summary
This bill amends the Texas Health and Safety Code to expand the list of substances classified as Schedule IV controlled substances. Currently, carisoprodol is the only substance in this category, but the bill adds two additional medications: mifepristone and misoprostol. Mifepristone is a medication primarily used for medical abortion, while misoprostol is a drug used to prevent stomach ulcers and also used in combination with mifepristone for medical abortion procedures. The bill specifies that the new classification will only apply to offenses committed on or after its effective date, which is September 1, 2025. By adding these substances to Schedule IV, the bill subjects them to additional regulatory controls and potential legal consequences related to their unauthorized possession, distribution, or use. The change does not criminalize the medical use of these medications when prescribed by a licensed healthcare professional, but rather establishes a legal framework for monitoring and controlling their distribution.
Committee Categories
Health and Social Services
Sponsors (2)
Last Action
Referred to Public Health (on 03/10/2025)
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
| Document Type | Source Location |
|---|---|
| State Bill Page | https://capitol.texas.gov/BillLookup/History.aspx?LegSess=89R&Bill=HB1339 |
| BillText | https://capitol.texas.gov/tlodocs/89R/billtext/html/HB01339I.htm |
Loading...